| scholarly article | Q13442814 |
| P50 | author | Jeffrey H Miner | Q58976191 |
| P2093 | author name string | Steven D Funk | |
| P2860 | cites work | Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice | Q28593330 |
| Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin | Q33922811 | ||
| An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. | Q34091913 | ||
| Mutations in the human laminin beta2 (LAMB2) gene and the associated phenotypic spectrum | Q34296921 | ||
| Self-assembly and calcium-binding sites in laminin. A three-arm interaction model | Q34352568 | ||
| Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. | Q35056189 | ||
| Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy | Q35952091 | ||
| Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages | Q36118063 | ||
| Laminin polymerization induces a receptor-cytoskeleton network | Q36342173 | ||
| The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy | Q36842039 | ||
| Nidogens-Extracellular matrix linker molecules | Q37064964 | ||
| Laminins and their roles in mammals | Q37064966 | ||
| 212th ENMC International Workshop: Animal models of congenital muscular dystrophies, Naarden, The Netherlands, 29-31 May 2015. | Q37555754 | ||
| Dystroglycanopathies: coming into focus | Q37852376 | ||
| The Pathogenesis and Therapy of Muscular Dystrophies | Q38517557 | ||
| Integrating Activities of Laminins that Drive Basement Membrane Assembly and Function. | Q38649033 | ||
| Laminin-α2 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment | Q38649036 | ||
| Chimeric protein repair of laminin polymerization ameliorates muscular dystrophy phenotype. | Q38951841 | ||
| Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice. | Q42478963 | ||
| Congenital muscular dystrophy: mini-agrin delivers in mice | Q45865539 | ||
| Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice | Q45876189 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | muscular dystrophy | Q1137767 |
| P304 | page(s) | 798-800 | |
| P577 | publication date | 2017-02-20 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Muscular dystrophy meets protein biochemistry, the mother of invention. | |
| P478 | volume | 127 |
| Q47164258 | Linker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice. | cites work | P2860 |
Search more.